Amicus Therapeutics, Inc.

NJ · United States · Reporting entity ID 100000381810

Total reported 2019–2025

$110.5M

#87 of 2,960 reporting companies — 0.1% of all reported industry payments

$2.30M in general payments across 1,813 records, plus $108.2M in research funding across 3,138 records.

How it breaks down

General payments $2,304,991

Research funding $108,183,413

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.